FDA approves Moderna's mRNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved [ a new seasonal flu vaccine ][15] from Moderna that uses mRNA technology, the drugmaker announced Wednesday. Called mFLUSIVA, it is approved for adults ages 50 and older. It's the first influenza vaccine using mRNA technology to receive FDA approv...